NICE Talks

National Institute of Health and Care Excellence (NICE)

0,0 (0)
Vetenskap
Varannan månad

NICE Talks is the podcast from UK's National Institute of Health and Care Excellence (NICE). Our podcast brings the stories behind our work to improve outcomes for people using the NHS and other public health and social care services through evidence-based guidance. Subscribe on your favourite podcast platform: https://linktr.ee/nicecomms

−1 d

PMOS: how the new draft NICE guideline could transform diagnosis and care

In this episode we explore the draft NICE guideline for PMOS (formerly known as PCOS), out for public consultation until 11 August 2026. We're joined by guideline committee members Aled Rees, professor of endocrinology at Cardiff University, and Sharon Manship, a lay member with lived experience of PMOS. Together they discuss how the recent name change, a new annual review, and a stronger focus on earlier diagnosis could transform care for the estimated 1 in 8 women living with the condition. Learn more: https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care Read the draft guideline: https://www.nice.org.uk/guidance/indevelopment/gid-ng10436/consultation/html-content-9
30 juni

Changing the course: the NHS's first treatment to delay type 1 diabetes

NICE has recommended teplizumab for NHS use — the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years. In this episode, we speak to Lucy Chambers, Head of Research Impact and Communications at Diabetes UK, and Amy Norman, whose daughter Imogen accessed teplizumab through a managed access programme after being identified through the ELSA screening study. Find out more: NICE recommendation for teplizumab: https://www.nice.org.uk/guidance/gid-ta10981/documents/html-content-10 | ELSA screening study (children aged 2–17): https://www.elsadiabetes.nhs.uk/taking-part/ | T1DRA trial (adults): https://t1dra.bristol.ac.uk/
27 maj

Treating babies at home with oral antibiotics

In this episode we discuss the recent changes to the NICE guideline for neonatal infections, that mean newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home, if they are doing well and responding to treatment. Guests: • Dr Tim Watts, guideline committee member and Consultant Neonatologist at the Evelina • Dr Harriet Aughey, Neonatal paediatrician at the Royal Devon and Exeter Hospital and co-lead on the NOAH (Neonatal Oral Antibiotics at Home) project • Emily Rose Jeffrey, mother to Luna took part in the NOAH trial Link to neonatal infections guideline: https://www.nice.org.uk/guidance/ng195 Link to news story: https://www.nice.org.uk/news/articles/nice-updates-neonatal-infection-guidance-to-allow-home-antibiotic-treatment-for-some-babies
29 apr.

Endometriosis fertility care and gynaecological cancer guidance

In this episode of NICE Talks, we're covering some of the most significant guidance updates of the year so far for women's health and cancer care. For the first time, NICE's updated fertility guideline includes a dedicated pathway specifically for people with endometriosis who are trying to conceive — a direct result of patient and clinician voices being heard during public consultation. We then turn to important updates to NICE's suspected cancer recognition and referral guideline, including changes to how ovarian cancer is investigated across different age groups and new guidance on endometrial cancer for people on HRT. Useful links: Fertility problems: assessment and treatment (NG257): https://www.nice.org.uk/guidance/ng257 Suspected cancer: recognition and referral (NG12): https://www.nice.org.uk/guidance/ng12
31 mars

Backing the healthtech that changes lives

When the right technology reaches the right patient, lives change. In this episode of NICE Talks, we hear directly from people whose lives have been transformed by NICE-recommended healthtech, including a hybrid closed loop system for type 1 diabetes, an implantable cardiac monitor to detect atrial fibrillation following a stroke, and a rapid genetic test that protects newborns from hearing loss caused by a common antibiotic. NICE's chief executive, Jonathan Benger, also shares our plans to support faster, fairer healthtech adoption across the NHS. Guests Jonathan Benger, NICE chief executive Ammaarah Ahmed and Aleix Rowlandson, who both benefit from a hybrid closed loop system to help manage their type 1 diabetes Peter Hooper, who was fitted with an implantable cardiac monitor to detect atrial fibrillation following his stroke Becky Ridley and baby Ginny, who benefitted from a rapid genetic test to help prevent hearing loss Caroline Knight who uses one-piece colostomy bags following bowel surgery Links Explore support for adopting or developing healthtech: https://www.nice.org.uk/what-nice-does/our-guidance/about-healthtech-guidance/nice-backing-the-healthtech-that-changes-lives NICE Advice service (for healthtech developers): www.nice.org.uk/niceadvice Subscribe to NICE News for Health and Social Care: www.nice.org.uk/nice-newsletters-and-alerts Subscribe to NICE News for Life Sciences: www.nice.org.uk/nice-newsletters-and-alerts Follow NICE on social media: search @NICEComms.
26 feb.

How NICE guidance is accelerating access to innovative migraine treatments

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. We're joined by Joanne McShane, an NHS health visitor who suffered from migraine for a decade; Dr Kay Kennis, GP with an extended role in Headache at Bradford Community Neurology Service; and Rob Music, chief executive at The Migraine Trust.
29 jan.

The asthma guideline – one year on

In this episode of NICE Talks, we learn the impact of the joint asthma guideline published in November 2024. Developed collaboratively by the British Thoracic Society, NICE and the Scottish Intercollegiate Guidelines Network, the guideline has transformed how asthma is diagnosed and treated across the UK. We hear from frontline clinicians putting the guidance into practice and from those who helped develop it – including a patient who has lived with asthma for 65 years. Guests Maria Eurton – Respiratory Nurse Specialist, working across a primary care network of eight GP surgeries in Southampton Nazir Hussain – Specialist Respiratory Pharmacist, Dudley Group NHS Foundation Trust Phil Taverner – Lay Member, Guideline Development Committee (living with asthma for 65 years) Dr Sunil Gupta – GP and Clinical Advisor for NICE The Guideline Joint BTS/NICE/SIGN Asthma Guideline: http://www.nice.org.uk/guidance/ng245
2025-12-31

Reviewing 2025: Producing faster rigorous guidance to make an impact on patient's lives

We look back on the guidance we've produced in 2025. We're joined by director of medicines evaluation Helen Knight, the deputy director of the centre for guidelines Eric Power, and Anastasia Chalkidou, the programme director of guidance delivery in HealthTech.

NICE Talks is the podcast from UK's National Institute of Health and Care Excellence (NICE). Our podcast brings the stories behind our work to improve outcomes for people using the NHS and other public health and social care services through evidence-based guidance. Subscribe on your favourite podcast platform: https://linktr.ee/nicecomms

Skapad av

National Institute of Health and Care Excellence (NICE)
Aktiva år

2018 - 2026
Avsnitt

87
Åldersgräns

Barnvänligt
Copyright

© All rights reserved
Programmets webbplats

NICE Talks